(PUL-moh-zime) A drug given in an aerosol mist to decrease the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. Pulmozyme contains an enzyme that breaks the DNA in mucus into small pieces and makes the mucus thinner. Also called dornase alfa inhalation solution.
- Browse Related Terms: AP5346, BMS-182751, cisplatin, dornase alfa inhalation solution, JM 216, lobaplatin, Pulmozyme, satraplatin